# Norketotifen for the Treatment of Uncomplicated Influenza-like Illness

> **NCT04043923** · PHASE2 · COMPLETED · sponsor: **Emergo Therapeutics, Inc.** · enrollment: 238 (actual)

## Conditions studied

- Influenza -Like Illness

## Interventions

- **DRUG:** Norketotifen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04043923
- **Lead sponsor:** Emergo Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-21
- **Primary completion:** 2020-04-05
- **Final completion:** 2020-04-20
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2021-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04043923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04043923, "Norketotifen for the Treatment of Uncomplicated Influenza-like Illness". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04043923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*